Skip to Content

Takhzyro Prices, Coupons and Patient Assistance Programs

Takhzyro (lanadelumab) is a member of the miscellaneous coagulation modifiers drug class and is commonly used for Hereditary Angioedema.

Takhzyro Prices

The cost for Takhzyro subcutaneous solution (300 mg/2 mL) is around $24,454 for a supply of 2 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

This Takhzyro price guide is based on using the discount card which is accepted at most U.S. pharmacies.

Subcutaneous Solution

300 mg/2 mL Takhzyro subcutaneous solution
from $24,453.78 for 2 milliliters
Quantity Per unit Price
2 milliliters $12,226.89 $24,453.78

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee. Printable Discount Card

The free Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Takhzyro Coupons and Rebates

Takhzyro offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Takhzyro OnePath Co-Pay Assistance Program: Eligible commercially insured patients may save up to 100% off co-pay expenses; for additional information contact the program at 866-888-0660.

Applies to:Takhzyro
Number of uses:Per prescription until program expires

Patient Assistance Programs for Takhzyro

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: OnePath Patient Assistance Program (TAKHZYRO)

Elligibility requirements:
  1. Determined case by case
  2. Not disclosed
  3. Medically appropriate condition/diagnosis
  4. The patient must also be residing in the US.
  5. This program provides copay assistance. Education and support services are available; Contact program for details.

Applicable drugs:

  • Takhzyro (lanadelumab) Injection; Subcutaneous